Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Tombach, B; Bohndorf, K; Brodtrager, W; Claussen, CD; Düber, C; Galanski, M; Grabbe, E; Gortenuti, G; Kuhn, M; Gross-Fengels, W; Hammerstingl, R; Happel, B; Heinz-Peer, G; Jung, G; Kittner, T; Lagalla, R; Lengsfeld, P; Loose, R; Oyen, RH; Pavlica, P; Pering, C; Pozzi-Mucelli, R; Persigehl, T; Reimer, P; Renken, NS; Richter, GM; Rummeny, EJ; Schäfer, F; Szczerbo-Trojanowska, M; Urbanik, A; Vogl, TJ; Hajek, P 
Titel:
Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial. 
Abstract:
The purpose of this phase III clinical trial was to compare two different extracellular contrast agents, 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine, for magnetic resonance imaging (MRI) in patients with known or suspected focal renal lesions. Using a multicenter, single-blind, interindividual, randomized study design, both contrast agents were compared in a total of 471 patients regarding their diagnostic accuracy, sensitivity, and specificity to correctly classify focal lesions of the k...    »
 
Zeitschriftentitel:
Eur Radiol 
Jahr:
2008 
Band / Volume:
18 
Heft / Issue:
11 
Seitenangaben Beitrag:
2610-9 
Sprache:
eng 
Print-ISSN:
0938-7994 
TUM Einrichtung:
r Radiologie